Global Drug Eluting Stent Market Size, Share & Trends Analysis Report 2023-2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Drug Eluting Stent Market Size, Share & Trends Analysis Report By Coating Type (Polymer-based Coatings (Non-biodegradable, Biodegradable)), Polymer-free Coatings, By Application, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

The global drug eluting stent market size is expected to reach USD 13.65 billion by 2030, advancing at a CAGR of 8.4%

An aging population and the increasing prevalence of risk factors such as cardiovascular diseases (CVDs), complex lesions, diabetes, obesity, and others are expected to drive the demand for drug eluting stents over the forecast period.

Additionally, ongoing technological advancements in stent design, including improvements in coatings and drug delivery mechanisms, are enhancing the safety and efficacy of these devices, making them more appealing to patients and healthcare professionals.

The increasing prevalence of cardiovascular diseases globally has fueled market demand. According to the World Health Federation report in 2022, over half a billion people globally continue to be affected by cardiovascular diseases, with CVD contributing to approximately 20.5 million deaths in 2021, accounting for nearly a third of all deaths globally.

Conditions like coronary artery disease and peripheral artery disease are becoming increasingly common, leading to a surge in demand for effective treatment options such as DES. These stents, equipped with drug-coated surfaces, offer patients a minimally invasive solution, effectively preventing restenosis and leading to improved patient outcomes.

The market for drug eluting stents was significantly impacted by the COVID-19 pandemic, with disruptions in the supply chain of medical devices. Since the focus of all major manufacturers was to fight the COVID-19 battle, the revenues of other segments were highly impacted. All notable competitors in the market for coronary stents announced a decline in revenue for their interventional cardiology portfolios, which include coronary stent devices in 2020, owing mostly to the impact of the COVID-19 pandemic.

Key Attributes:

Drug Eluting Stent Market Report Highlights

• Based on coating, the polymer-based coating segment held the dominant revenue share of 82.9% in 2022. This share can be attributed to its extensive usage in stent development, proven efficacy in drug delivery, and versatility in accommodating various therapeutic agents, making it a preferred choice for manufacturers and healthcare professionals alike. Additionally, continuous advancements in polymer-based coating technology have further solidified its leading position in the market
• Based on application, the market for drug eluting stents has been categorized into coronary artery disease and peripheral artery disease, with the former accounting for 85.9% of the revenue share in 2022. The growth can be attributed to the high prevalence of coronary artery disease globally, leading to a substantial demand for effective treatment options such as drug eluting stents
• The North American region held the largest revenue share of 43.08% in 2022 and is expected to dominate the market through the forecast period. North America has a well-developed and advanced healthcare infrastructure, including hospitals. Additionally, the increasing prevalence of cardiovascular diseases in the region has driven the demand for effective treatment options such as drug eluting stents

Competitive Landscape

• Abbott Laboratories
• Boston Scientific Corporation
• Terumo Corporation
• Medtronic
• Biosensors International
• Cook Medical
• B. Braun
• Biotronik
• Lepu Medical Technology

Key Topics Covered:

Chapter 1. Methodology and Scope

1.1. Information Procurement

1.2. Information Or Data Analysis

1.3. Market Scope & Segment Definition

1.4. Market Model

1.4.1. Market Study, By Company Market Share

1.4.2. Regional Analysis

Chapter 2. Executive Summary

2.1. Market Snapshot

2.2. Segment Snapshot

2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Segmentation and Scope

3.2. Market Lineage Outlook

3.2.1. Parent Market Outlook

3.2.2. Related/Ancillary Market Outlook

3.3. Market Trends and Outlook

3.4. Market Dynamics

3.4.1. Increasing Prevalence of Cardiovascular Diseases

3.4.2. Technological Advancements in Stent Design

3.4.3. Growing Geriatric Population

3.5. Market Restraint Analysis

3.5.1. High Cost of Drug Eluting Stents

3.6. Penetration And Growth Prospect Mapping 2022

3.7. Business Environment Analysis

3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)

3.7.2. Porter's Five Forces Analysis

3.8. COVID-19 Impact Analysis

Chapter 4. Drug Eluting Stent Market: Coating Type Segment Analysis

4.1. Drug Eluting Stent: Market Share Analysis, 2022 & 2030

4.2. Polymer-Based Coating

4.2.1. Polymer-Based Coating Market, 2018 - 2030 (USD Billion)

4.2.1.1. Non-Biodegradable Polymers

4.2.1.2. Biodegradable Polymers

4.3. Polymer-free Coating

4.3.1. Polymer-Free Coating Market, 2018 - 2030 (USD Billion)

4.3.1.1. Micro Porous Surface

4.3.1.2. Micro Structured Surface

4.3.1.3. Slotted Tubular Surface

4.3.1.4. Nanoporous Surface

Chapter 5. Drug Eluting Stent Market: Application Segment Analysis

5.1. Drug Eluting Stent: Market Share Analysis, 2022 & 2030

5.2. Coronary Artery Disease

5.2.1. Coronary Artery Disease Market, 2018 - 2030 (USD Billion)

5.3. Peripheral Artery Disease

5.3.1. Peripheral Artery Disease Market, 2018 - 2030 (USD Billion)

Chapter 6. Drug Eluting Stent Market: Regional Analysis

6.1. Drug Eluting Stent Market Share, By Region, 2022 & 2030

For more information about this report visit https://www.researchandmarkets.com/r/sb0lsc

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900